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Abstract
This paper provides a brief overview of the harm reduction programme for injecting drug users
(IDU) of CARE, Bangladesh in Dhaka city and uses data from surveillance and a focussed research
study on a cohort of IDU, to evaluate the programme. The harm reduction programme in Dhaka
is run by CARE, Bangladesh and includes needle/syringe exchange, awareness raising on HIV/STI,
abscess management, condom distribution and advocacy with different groups of people. The
needle/syringe exchange programme (NEP) has been in place since 1998, the 2nd Generation
Surveillance in Bangladesh is being conducted since 1998, and an in-depth cohort study, started in
2002, is being conducted in two areas of Dhaka city with approximately 500 IDU under CARE's
NEP who are being followed bi-annually to assess risk behaviour, incidence of HIV, hepatitis C and
syphilis. As the surveillance and the cohort study are both closely associated with the NEP of
CARE, Bangladesh, these data can be used to monitor the NEP.
Review
Harm Reduction Programme for IDU in Dhaka city
The number of injecting drug users (IDU) in Bangladesh
is not known. In a Rapid Situation Assessment conducted
in 2002 [1] IDU were found in 20/24 sites studied and
although this assessment was not an exercise in enumerat-
ing the number of drug users in the country, it was appar-
ent that the maximum number of IDU were in the capital
city, Dhaka. CARE, Bangladesh started a needle/syringe
exchange programme (NEP) in Dhaka in 1998 covering
approximately 880 IDU. This NEP has expanded over the
years and in 2004, IDU in 19 districts of Bangladesh were
reached by CARE, Bangladesh and at the same time in
Dhaka the number of IDU that were being reached had
increased to approximately 4400, with 3900 being regular
attendees. The NEP services in Dhaka are are coordinated
through a central field office and provided through 21
Drop-In Centres (DIC) which are located within or close
to communities of IDU and through out reach workers in
the field. The services provided include needle/syringe
exchange in the field, DIC based clinical services for the
management of abscesses and sexually transmitted infec-
tions (STIs), drug detoxification camps, condom distribu-
tion, education and awareness on the harmful effects of
drugs, safe injections, HIV/AIDS, STIs, other blood borne
infections. Presently, the average number of needles/
syringes given to each IDU in Dhaka is five per week and
condoms are being received by 15% of IDU. Of the regis-
tered IDU, 55% are married however, there is no specific
programme to reach the sex partners of IDU, rather IDU
are encouraged to bring their sex partners to the DIC for
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STI management. In the last year 87 sex partners received
STI treatment from the DIC.
In addition to these services, advocacy constitutes a major
part of CARE, Bangladesh's intervention programme for
IDU. Advocacy is done with members of the community,
law enforcing agencies, policy makers from the govern-
ment, general community leaders, NGOs, and Develop-
ment Partners as and when required. Special local level
advocacy meetings are held at the community level when
problems are faced in the field.
In Dhaka, harm reduction services to IDU are provided
almost exclusively by CARE, Bangladesh. Other organisa-
tions are providing detoxification and some rehabilitation
services, and some also provide clinical management for
STIs but their clientele are primarily non-injecting drug
users.
Data for evaluating the NEP
National Surveillance
Second Generation Surveillance for HIV is being con-
ducted in Bangladesh since 1998 and IDU are one of the
population groups sampled in surveillance and they have
been accessed from several cities [2-7]. The surveillance
system in Bangladesh has the serological and Behavioural
Surveillance System (BSS) components, which are con-
ducted in tandem on similar groups, but not the same
individuals and the methodologies for sampling for the
two systems are different. The serological system sampled
IDU exclusively through the NEP of CARE, Bangladesh
and most of the IDU sampled in BSS were members of the
NEP. Given that the surveillance is so closely linked to the
intervention programmes, data from the surveillance sys-
tem can be used to monitor intervention programmes for
IDU, i.e. the NEP of CARE, Bangladesh, as that has the
only ongoing harm reduction programme with IDU in
Dhaka. Five rounds of surveillance have been completed
and as IDU have been sampled from the NEP since the 2nd
round (1999–2000), data from the 2nd to the 5th (2003–
2004) rounds have been used in this evaluation.
Serological Surveillance
The serological surveillance in Bangladesh accesses IDU
through intervention programmes [6] and the reason for
this is that blood samples cannot be collected in the field
setting and results of syphilis tests and treatment for syph-
ilis can only be provided to the IDU in a clinical setting.
For serological surveillance, IDU have been accessed
annually through harm reduction NGOs with extensive
outreach into the community (i.e. CARE, Bangladesh)
since the 2nd round (1999–2000) and since the 3rd round
(2000–2001) this has been exclusive source of IDU as pre-
vious attempts at accessing IDU through detoxification
clinics yielded very few IDU.
Serological surveillance has recorded a rise in HIV preva-
lence over the rounds in IDU from the NEP in Central
Bangladesh with prevalence rising from at 1.4% in 1999–
2000 (2nd  round) to 4.0% in 2002 (4th  round) and
remaining at 4% during the 5th round (2003–2004) (p <
0.001) [3,8]. Although in the 5th round the HIV preva-
lence has remained at 4%, in one particular neighbour-
hood in the same city, the prevalence was recorded at
8.9% (95% CI: 5.4–14.4%) [7]. These findings show that
HIV is gradually rising within the IDU in this city and at
present most of the cases are localised to one neighbour-
hood, which may be the epicentre of the epidemic. High
rates of hepatitis C have been recorded in the IDU from
the very beginning of surveillance and these rates have
remained high throughout (66.5% in 2nd round, 62.3% in
the 4th round and 59.2% in the 5th round) [7,8]. High hep-
atitis C rates suggest risky injection and drug sharing
behaviours [9]. In contrast to HIV and hepatitis C, active
syphilis rates declined significantly over the rounds (9.3%
in the 2nd round to1.2% in the 5th round, p < 0.001) [7]
suggesting that interventions for sexual risk are possibly
being addressed successfully.
Behavioural Surveillance System
A two-stage cluster sampling was used in BSS [6]. In the
first stage a time location systematic random sampling
method was employed to select primary sampling units
(PSUs) and in the second stage the numbers of respond-
ents to be interviewed from each PSU was calculated. The
PSU for IDU were spots where at least three IDU were
found in a specific time frame. Through this method of
sampling IDU selected included both those who were in
and out of intervention programmes although in the 5th
round most IDU sampled were members of the NEP of
CARE, Bangladesh. The data used for evaluation are from
the 4th and 5th rounds of BSS.
During the 4th round of BSS conducted in 2002, 44.5%
(95% CI: 34.6–54.8%) of the IDU sampled from Central
city A were under the NEP of CARE, Bangladesh and this
increased to 88.3% (95% CI: 84.4–91.4%) during the 5th
round in 2003–2004 (p < 0.001). Analyses of data from
the 4th round of BSS showed that IDU in interventions
practice safer behaviours than those out of intervention
[10] and fewer IDU within interventions shared needles/
syringes and reported STIs than IDU outside of interven-
tions [11] whereas more IDU within interventions who
reported STIs in the last year sought treatment [11]. These
findings suggested that the NEP might be having some
preventive effect. However, although, coverage increased
between the 4th and 5th rounds of surveillance, borrowing
of used needles/syringes by IDU during the last week also
increased from 65.8% (95% CI: 60.1–71.1%) in 2002 to
86% (95% CI: 82.4–89.0%) in 2004 (p < 0.001). Unfor-
tunately BSS cannot provide reasons for changes in behav-Harm Reduction Journal 2005, 2:22 http://www.harmreductionjournal.com/content/2/1/22
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iours seen but field observations at the time of
surveillance suggested that considerable disruption
occurred in the field due to "cleaning" drives by the com-
munity and law enforcement agencies which drove the
IDU underground from their regular shooting spots. Nine
such observations were recorded during mapping and
interviewing for BSS over a three month period.
IDU are not only at risk of acquiring HIV through injec-
tion sharing but also through unprotected sex [12] which
can also allow transmission to other non-IDU partners in
their sexual network [13-15]. In Bangladesh, BSS data
show that IDU in Central city A are sexually active and in
the 5th round of BSS, in the last year 34.5% (95% CI: 29.4–
40.0%) bought sex from female sex workers, 2.3% (95%
CI: 1.2–4.6%) from male sex workers and 35.7% (95% CI:
29.6–42.3%) had regular non-commercial female sex
partners. Although the proportion of IDU who bought sex
declined between the 4th and 5th rounds of surveillance (p
< 0.001) fewer IDU reported using condoms in the last sex
act with female sex workers in the 5th round 15.7% (95%
CI: 10.3–23.3%) compared to the 4th round (29.3%, 95%
CI: 23.5–35.9%) of surveillance (p = 0.005). These find-
ings indicate that sexual behaviour in those IDU involved
in commercial sex has become riskier.
As the BSS sampled IDU from the same areas of the city as
the serological surveillance, secondary analyses of the 5th
round of BSS data was done to assess whether there were
behavioural factors associated with the localised epidemic
of HIV recorded by serological surveillance in IDU in a
neighbourhood of Central city A (unpublished observa-
tions). BSS data from IDU were compared between the
neighbourhood with the concentrated HIV epidemic
(referred to as area 1) and the rest of the city. In brief, such
comparisons revealed that IDU from area 1 were from a
lower socio-economic status being significantly less edu-
cated, having a lower monthly average income and more
commonly living on the street (p ≤ 0.001 for all) than IDU
from the rest of the city. In area 1, IDU took more injec-
tions on average in the last day and in the last week (p <
0.001 for both) compared to the IDU in the rest of the city
although no differences were observed in injection shar-
ing behaviour between the two areas. However, among
those IDU who shared in the last week and said they had
shared with different partners, the mean number of per-
sons that shared injections were higher in area 1 than in
the rest of the city (p = 0.026). Moreover, IDU in area 1
had a lower risk perception than those in the rest of the
city. Therefore, there appear to be neighbourhood factors
that enhance vulnerability of the IDU to HIV. From these
data it is not possible to gage what these factors may be
but in other countries factors such as neighbourhood
socio-economic status have been shown to play a role in
fuelling the HIV epidemic [16,17].
Research study on a cohort of IDU
A research study on a cohort of IDU in two areas of Dhaka
city within the NEP of CARE, Bangladesh is ongoing. This
study has been focussing on the incidence of HIV, hepati-
tis C and syphilis and risk behaviours of IDU within the
NEP. Preliminary findings obtained at the baseline of the
cohort study in 2002 showed that there is a localised epi-
demic (5.9%; 95% CI: 4.2–8.1%) within the cohort of
561 IDU and that in one of the two areas under study the
prevalence is 8.0% (95% CI: 5.7–11.1% [18], the same
neighbourhood that has recorded an epidemic during the
5th round of surveillance.
Baseline data from the IDU within the cohort showed that
27.7% (95% CI: 24.1–31.5%) and 34.5% (95% CI: 30.7–
38.6%) IDU borrowed and lent used needles/syringes,
respectively, in the last week despite being in the NEP
[18]. Almost half the IDU (48.3%; 95% CI: 44.4–52.6%)
obtained their needles/syringes from the NEP as well as
drug stores. The reasons for obtaining needle/syringes
outside the NEP and for sharing needles/syringes included
not having access to outreach workers while injecting
(13.2%; 95% CI: 10.0–17.4%), not having needles/
syringes with themselves at the time of injection (16%;
95% CI: 12.4–20.4%), not having adequate knowledge
about HIV/AIDS (14.2%; 95% CI: 10.8–18.4%), inade-
quate supply of needle/syringe by the NEP (3.1%; 95% CI:
1.7–5.6%) and a combination of these (33.2%; 95% CI:
28.3–38.5%). In addition, the IDU complained of harass-
ment by law enforcers and the community, poor abscess
management, inadequate access to medical treatment and
detoxification services. Similar to the BSS data, a signifi-
cant proportion of IDU in the cohort also reported unsafe
sexual behaviour (data not shown).
Response of CARE, Bangladesh to the data
In response to data from surveillance and the cohort
study, CARE, Bangladesh increased its coverage of IDU in
Dhaka city and in the neighbourhood where the epidemic
was recorded and took some specific actions to improve
their programme [19]. To increase the likelihood of hav-
ing access to outreach workers at the time of injection, the
number of outreach workers in the field for distributing
needles/syringes were increased from 12 in a month in
January 2003 to 100 in December 2003; the number of
shifts during which needles/syringes are distributed were
increased from one to two daily; and needles/syringes
exchange in the field was supervised more closely. To
reduce the harassment that IDU face from law enforcing
agencies, CARE, Bangladesh increased its advocacy efforts
with law enforcers, community and policy makers. Since
the study started, monthly visits of IDU in the two study
DICs of the IDU increased between January and October
2003 from 337 to 1118 in area A and 548 to 1217 in area
B. Similarly, the numbers of IDU whose abscesses wereHarm Reduction Journal 2005, 2:22 http://www.harmreductionjournal.com/content/2/1/22
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managed increased during the same time at those DICs
(from 83 to 278 in area A and 127 to 219 in area B). A hos-
pital willing to provide medical services to IDU such as
management of severe abscesses, orthopaedic services,
surgery, etc was identified to which IDU are now referred.
Through the cohort study 40 HIV positive IDU have been
identified and these HIV positive IDU have raised new
demands mainly related to their clinical management and
maintenance of confidentiality. Counsellors and a physi-
cian from ICDDR,B were appointed especially for their
needs and CARE, Bangladesh formed a support group of
HIV positive IDU and their partners. CARE, Bangladesh
also opened a new DIC for the HIV positive IDU, which is
also open for any IDU wishing to attend so as not to dis-
criminate between the HIV positive and negative IDU.
Through this DIC medical care and counselling has
become much easier and more regular. So far there has
been no breach in confidentiality.
Conclusion
At present the HIV prevalence is still low in IDU but and
although in some aspects sex practices may have become
safer, injection sharing behaviour has become riskier.
Given the high levels of continued risk behaviour and
hepatitis C prevalence, the frequent disturbances in the
field interfering with the programme activities and that
one area of Dhaka city is already experiencing a localised
epidemic of HIV, if all out efforts from all quarters are not
made, the epidemic is likely to spread in the near future.
Available data suggest that the NEP in Dhaka is responsive
to the data generated but the responses have been insuffi-
cient in changing their injection sharing practices. The
harm reduction programme has to develop a more com-
prehensive response and as there are neighbourhood dif-
ferences the programme also needs to address a broader
environment, which may be making the IDU more vul-
nerable in that neighbourhood. Consideration of struc-
tural interventions may be necessary if an HIV epidemic is
to be averted.
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